UPDATED: Merck’s oral COVID-19 antiviral slashes hospitalizations, prevents deaths in phase 3, sparking race to file with FDA
UPDATED: Merck’s oral COVID-19 antiviral slashes hospitalizations, prevents deaths in [...]
UPDATED: Merck’s oral COVID-19 antiviral slashes hospitalizations, prevents deaths in [...]
Micreos lands $37M to show whether antibiotic alternative delivers in [...]
AstraZeneca is nearly ready to seek approval for its COVID-19 [...]
Lilly adds liver fat, CGM blood sugar data to mountain [...]
Sunovion pens $890M Otsuka pact for a clutch of neuropsychiatric [...]
Researchers unravel the genetic cause of a childhood disorder and [...]
Amicus spins off gene therapy unit in $600M SPAC deal [...]
I-Mab hits the deal table with biopharma majors to talk [...]
How exploiting a protective gene mutation might protect the brain [...]
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a [...]